Home About Services Portfolio Careers FAQ Contact Request a Quote

Services › Terumo BCT › Reveos

Automated Blood Processing

The Future of Whole Blood
Automation Is Here.

The Reveos® Automated Blood Processing System revolutionises whole blood processing — improving lab efficiency, blood component quality, and process control on a single platform.

Request a Demo View Specifications
Terumo Reveos Automated Blood Processing System

Overview

One Platform.
Three Components.
Complete Automation.

The Reveos system processes whole blood units automatically into leukoreduced red blood cells, platelets, and plasma — with significantly less manual effort and more consistent results than semi-automated buffy coat methods.

  • Processes 12 units simultaneously into RBCs, platelets & plasma
  • Fully automated separation — minimal operator intervention required
  • Standardises results across every run for reproducible quality
  • Reduces hands-on processing steps by up to 65%
  • Compatible with fresh blood and overnight hold protocols
  • T-pool Select tool for automated platelet pooling
  • Full electronic traceability on all units processed
  • Single operator can manage multiple Reveos devices simultaneously

By the Numbers

Performance That Speaks for Itself

65% Fewer hands-on steps vs. semi-automated buffy coat
24 min Faster processing of 12 units vs. buffy coat method
35 min Faster platelet pooling vs. manual buffy coat method
<1×10⁶ WBC per unit — meets EU EDQM leukoreduction standards

Why Reveos

Built on Three Core Pillars

High Quality. Low Variability.

Automation enables standardisation and traceability — maintaining blood component quality and minimising procedural errors across every unit processed.

55.4 g/unit Haemoglobin content with Reveos vs. 48.1 g/unit with buffy coat (P < 0.050)
  • Higher Hct: 60.0% ±4.9% vs. 58.9% ±6.5% (buffy coat)
  • Meets EDQM specs — fresh blood & overnight hold protocols
  • Reduced procedural errors through full automation

Productivity You Can Measure

Reveos processes an entire run up to 60 minutes faster than the buffy coat method — freeing your team to focus on higher-value tasks.

60 min Reduction in whole blood processing time vs. buffy coat method
  • 12 units processed simultaneously per run
  • 24 min faster per run vs. semi-automated buffy coat
  • 35 min faster platelet pooling with T-pool Select

Confidence in Every Unit

Reduce manual intervention significantly — Reveos cuts hands-on processing steps by up to 65%, lowering the risk of human error and improving staff safety.

65% Fewer hands-on steps vs. semi-automated processing methods
  • Minimises risk of contamination and human error
  • Electronic traceability on every processed unit
  • Consistent results regardless of operator

Head-to-Head

Reveos vs. Buffy Coat Method

Clinical data comparing Reveos to semi-automated buffy coat processing across key quality and efficiency indicators.

Metric Buffy Coat (Semi-Automated) Reveos®
Haemoglobin Content 48.1 ±7.6 g/unit 55.4 ±6.6 g/unit
Haematocrit 58.9% ±6.5% 60.0% ±4.9%
WBC Leukoreduction Varies by method <1 × 10⁶ WBC — meets EU EDQM
Processing Time (12 units) Baseline 24 minutes faster
Total Processing Time Baseline Up to 60 minutes faster
Platelet Pooling Time Manual baseline 35 minutes faster (T-pool Select)
Hands-on Steps Baseline Up to 65% fewer
Operator Dependency High Low — automated & standardised
Traceability Manual documentation Full electronic traceability
Protocol Support Fresh blood only (typical) Fresh blood & overnight hold

Data on file. Pérez-Rus G et al. Transfusion and Apheresis Science. 2019. Cardigan R et al. Transfusion Medicine and Hemotherapy. 2021. Results may vary based on site-specific conditions and protocols.

Scalability

Grows With Your Blood Centre

Whether you process 18,000 or 288,000 units per year, Reveos scales to meet your demand. A single operator can manage multiple devices — so growth doesn't require a proportional increase in staffing.

~18,000 units / year
1 device · 1 operator
~36,000 units / year
2 devices · 1 operator
~72,000 units / year
4 devices · 1 operator
~288,000 units / year
16 devices · 4 operators

"Remodelling whole blood processing through automation and pathogen reduction technology delivers measurable improvements in component quality, staff efficiency, and process control."

— Luxembourg Red Cross, case study published in Transfusion and Apheresis Science

Technical Details

Full Specifications

System TypeAutomated whole blood processing
Components ProducedLeukoreduced RBCs, pooled platelets (T-pool Select), plasma
Units Per RunUp to 12 whole blood units simultaneously
Haemoglobin Content55.4 ±6.6 g/unit (vs. 48.1 ±7.6 g/unit buffy coat; P < 0.050)
Haematocrit60.0% ±4.9% (vs. 58.9% ±6.5% buffy coat)
Leukoreduction Standard<1 × 10⁶ WBC per unit — meets EU EDQM specifications
Protocol SupportFresh blood and overnight hold protocols
Platelet PoolingT-pool Select automated pooling (35 min faster vs. manual)
Processing Time AdvantageUp to 60 min faster total; 24 min faster per 12-unit run
Hands-on Step ReductionUp to 65% fewer steps vs. semi-automated methods
TraceabilityFull electronic tracking and audit trail on all units
Operator ModelSingle operator can manage multiple devices simultaneously
Annual Throughput~18,000 units/year (1 device) to ~288,000 units/year (16 devices)
ManufacturerTerumo Blood and Cell Technologies
More InformationTerumoBCT.com/Reveos

Lead Your Blood Centre With Reveos

Contact QLS Jamaica to arrange a demonstration, process comparison, or ROI discussion for your facility.

Request a Demo